Surveillance des enfants après un cancer: l'exemple du RIFHOP : L'après-cancerMICHON, Jean.Concours médical (Paris). 2011, Vol 133, Num 1, pp 26-27, issn 0010-5309, 2 p.Article

CONTRIBUTION A L'ETUDE DE LA SOUS-STRUCTURATION EXPERIMENTALE = A CONTRIBUTION TO THE STUDY OF EXPERIMENTAL SUBSTRUCTURINGMICHON JEAN CLAUDE.1981; ; FRA; DA. 1981; 130 P.; 30 CM; BIBL. 40 REF.; TH. DOCT.-ING./NANTES/1981Thesis

COURBES DE SHIMURA HYPERELLIPTIQUES = HYPERELLIPTICAL SHIMURA CURVESMICHON JEAN FRANCIS.1980; ; FRA; DA. 1980; 19 P.; 30 CM; BIBL. 9 REF.; TH. 3E CYCLE: MATH./PARIS 7/1980Thesis

ROLE OF PALLIATIVE RADIOTHERAPY IN THE MANAGEMENT OF METASTATIC PEDIATRIC NEUROBLASTOMA: A RETROSPECTIVE SINGLE-INSTITUTION STUDYCAUSSA, Lucas; HIJAL, Tarek; MICHON, Jean et al.International journal of radiation oncology, biology, physics. 2011, Vol 79, Num 1, pp 214-219, issn 0360-3016, 6 p.Article

Un exemple d'indicateurs de gestion des forêts publiques. Analyse des relations spatiales entre population et forêt = Some indicators for managing public forests. An analysis of the spatial relations between population and forestMICHON, Jean-Marie; HERMELINE, Michel.Revue Forestière Française. 2001, Vol 53, Num 3-4, pp 277-282, issn 0035-2829Conference Paper

On maximal Qrobdd's of boolean functionsMICHON, Jean-Francis; YUNES, Jean-Baptiste; VALARCHER, Pierre et al.Informatique théorique et applications (Imprimé). 2005, Vol 39, Num 4, pp 677-686, issn 0988-3754, 10 p.Article

Le traitement des enfants atteints d'un neuroblastome de haut risque: vers une nouvelle prise en charge = A new treatment strategy for children with high-risk neuroblastomaMICHON, Jean; LEVY, Dominique.MTP. Médecine thérapeutique pédiatrie. 2013, Vol 16, Num 4, pp 308-312, issn 1286-5494, 5 p.Article

Les altérations génétiques dans le neuroblastome et leur apport pour La prise en charge thérapeutique = Genetic alterations in neuroblastoma and their usefulness for clinical managementNORMAND, Charline; MICHON, Jean; JANOUEIX-LEROSEY, Isabelle et al.Bulletin du cancer. 2011, Vol 98, Num 5, pp 477-488, issn 0007-4551, 12 p.Article

Excellent Outcome With Reduced Treatment for Infants With Disseminated Neuroblastoma Without MYCN Gene AmplificationDE BERNARDI, Bruno; GERRARD, Mary; BRICHARD, Benédicte et al.Journal of clinical oncology. 2009, Vol 27, Num 7, pp 1034-1040, issn 0732-183X, 7 p.Article

Outcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut CurieAERTS, Isabelle; PACQUEMENT, Hélène; QUINTANA, Erica et al.European journal of cancer (1990). 2004, Vol 40, Num 10, pp 1522-1529, issn 0959-8049, 8 p.Article

Correlation of early metastatic response by ¹²³I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastomaMATTHAY, Katherine K; EDELINE, Veronique; LUMBROSO, Jean et al.Journal of clinical oncology. 2003, Vol 21, Num 13, pp 2486-2491, issn 0732-183X, 6 p.Article

Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma Without MYCN Amplification: Results of the Prospective INES 99.1RUBIE, Hervé; DE BERNARDI, Bruno; BROCK, Penelope et al.Journal of clinical oncology. 2011, Vol 29, Num 4, pp 449-455, issn 0732-183X, 7 p.Article

Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood : A case-control studyGUERIN, Sylvie; GUIBOUT, Catherine; DE VATHAIRE, Florent et al.International journal of cancer. 2007, Vol 120, Num 1, pp 96-102, issn 0020-7136, 7 p.Article

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescentsCAIRO, Mitchell S; GERRARD, Mary; PATTE, Catherine et al.Blood. 2007, Vol 109, Num 7, pp 2736-2743, issn 0006-4971, 8 p.Article

Identification of β-tubulin isoforms as tumor antigens in neuroblastomaPRASANNAN, Latha; MISEK, David E; HINDERER, Robert et al.Clinical cancer research. 2000, Vol 6, Num 10, pp 3949-3956, issn 1078-0432Article

ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndromeBOURDEAUT, Franck; FERRAND, Sandrine; ISIDOR, Bertrand et al.European journal of human genetics. 2012, Vol 20, Num 3, pp 291-297, issn 1018-4813, 7 p.Article

Accompagner un enfant en fin de vie: à domicile ou à l'hôpital ?AUVRIGNON, Anne; CHOISNARD, Hervé; GIOIA, Martine et al.MTP. Médecine thérapeutique pédiatrie. 2009, Vol 12, Num 3, pp 123-125, issn 1286-5494, 3 p.Article

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastomaJANOUEIX-LEROSEY, Isabelle; LEQUIN, Delphine; VALTEAU-COUANET, Dominique et al.Nature (London). 2008, Vol 455, Num 7215, pp 967-970, issn 0028-0836, 4 p.Article

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents : it is possible to reduce treatment for the early responding patientsPATTE, Catherine; AUPERIN, Anne; CAIRO, Mitchell S et al.Blood. 2007, Vol 109, Num 7, pp 2773-2780, issn 0006-4971, 8 p.Article

Results of induction chemotherapy in children older than 1 year with a stage 4 Neuroblastoma treated with the nb 97 french society of pediatric oncology (SFOP) protocolVALTEAU-COUANET, Dominique; MICHON, Jean; CHASTAGNER, Pascal et al.Journal of clinical oncology. 2005, Vol 23, Num 3, pp 532-540, issn 0732-183X, 9 p.Article

High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with International Neuroblastoma Staging System Stage II and III Neuroblastoma with MYCN amplificationLAPRIE, Anne; MICHON, Jean; BERGERON, Christophe et al.Cancer. 2004, Vol 101, Num 5, pp 1081-1089, issn 0008-543X, 9 p.Article

Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized Ewing tumorSCHLEIERMACHER, Gudrun; PETER, Martine; DELATTRE, Olivier et al.Journal of clinical oncology. 2003, Vol 21, Num 1, pp 85-91, issn 0732-183X, 7 p.Article

Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 TrialLE DELEY, Marie-Cécile; PAULUSSEN, Michael; VAN DEN BERG, Henk et al.Journal of clinical oncology. 2014, Vol 32, Num 23, pp 2440-2448, issn 0732-183X, 9 p.Article

Cholinergic switch associated with morphological differentiation in neuroblastomaBOURDEAUT, Franck; JANOUEIX-LEROSEY, Isabelle; PEUCHMAUR, Michel et al.Journal of pathology (Print). 2009, Vol 219, Num 4, pp 463-472, issn 0022-3417, 10 p.Article

Poor Survival for Infants With MYCN-Amplified Metastatic Neuroblastoma Despite Intensified Treatment : The International Society of Paediatric Oncology European Neuroblastoma ExperienceCANETE, Adela; GERRARD, Mary; DE BERNARDI, Bruno et al.Journal of clinical oncology. 2009, Vol 27, Num 7, pp 1014-1019, issn 0732-183X, 6 p.Article